scispace - formally typeset
Open AccessJournal ArticleDOI

MYC and tumor metabolism: chicken and egg

Francesca R Dejure, +1 more
- 01 Dec 2017 - 
- Vol. 36, Iss: 23, pp 3409-3420
TLDR
The main hypothesis is that regulation of MYC levels is an integral part of the adaptation of cells to nutrient deprivation and that maintaining flexibility of expression is integral to MYC's oncogenic function.
Abstract
Transcription factors of the MYC family are deregulated in the majority of all human cancers. Oncogenic levels of MYC reprogram cellular metabolism, a hallmark of cancer development, to sustain the high rate of proliferation of cancer cells. Conversely, cells need to modulate MYC function according to the availability of nutrients, in order to avoid a metabolic collapse. Here, we review recent evidence that the multiple interactions of MYC with cell metabolism are mutual and review mechanisms that control MYC levels and function in response to metabolic stress situations. The main hypothesis we put forward is that regulation of MYC levels is an integral part of the adaptation of cells to nutrient deprivation. Since such mechanisms would be particularly relevant in tumor cells, we propose that-in contrast to growth factor-dependent controls-they are not disrupted during tumorigenesis and that maintaining flexibility of expression is integral to MYC's oncogenic function.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

The Anti-Cancer Effect of Quercetin: Molecular Implications in Cancer Metabolism.

TL;DR: The role of quercetin in cancer metabolism is discussed, addressing specifically its ability to target molecular pathways involved in glucose metabolism and mitochondrial function.
Journal ArticleDOI

PKM2, function and expression and regulation

TL;DR: This paper will use the switching effect of PKM2 in glucose metabolism as the entry point to expand and enrich the Warburg effect, and illustrate the different intracellular localization ofPKM2 and then exert specific biological functions.
Journal ArticleDOI

Immunity, Hypoxia, and Metabolism-the Ménage à Trois of Cancer: Implications for Immunotherapy.

TL;DR: This review will discuss how a metabolic characterization of the TME can identify novel targets and signatures that could be exploited in combination with standard immunotherapies and can help to predict the benefit of new and traditional immunotherapeutic drugs.
Journal ArticleDOI

The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis

TL;DR: It is suggested that oncogenic activation of MYC and/or loss of a MYC antagonist, results in an imbalance in the activity of the network as a whole, leading to tumor initiation, progression and maintenance.
References
More filters
Journal ArticleDOI

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

TL;DR: It is proposed that the metabolism of cancer cells, and indeed all proliferating cells, is adapted to facilitate the uptake and incorporation of nutrients into the biomass needed to produce a new cell.
Journal ArticleDOI

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

TL;DR: This review examines the idea that several core fluxes, including aerobic glycolysis, de novo lipid biosynthesis, and glutamine-dependent anaplerosis, form a stereotyped platform supporting proliferation of diverse cell types and regulates regulation of these fluxes by cellular mediators of signal transduction and gene expression.
Journal ArticleDOI

The Warburg Effect: How Does it Benefit Cancer Cells?

TL;DR: Several proposed explanations for the function of Warburg Effect are analyzed, emphasize their rationale, and discuss their controversies.
Journal ArticleDOI

MYC on the Path to Cancer

TL;DR: The richness of the understanding of MYC is reviewed, highlighting new biological insights and opportunities for cancer therapies.
Journal ArticleDOI

Endoplasmic reticulum stress: cell life and death decisions

TL;DR: Important roles for ER-initiated cell death pathways have been recognized for several diseases, including hypoxia, ischemia/reperfusion injury, neurodegeneration, heart disease, and diabetes.